We found that the adoptive transfer of CXCR4+ B cells combined with CXCL12 effectively inhibited HCC progression (Figure 5B,C) and prolonged the survival time of tumor‐bearing mice (Figure 5D). This evidence concerns the gene CXCL12 and neoplasm.